Sign Out
Clear to opalescent solution, colourless to slightly brownish, pH 5.2-5.8, osmolality of 270-370 and 275-375 mOsmol/kg for the 1200 mg/600 mg and 600 mg/600 mg solutions, respectively.
Phesgo 600 mg/600 mg solution for injection: One vial of 10 mL solution contains 600 mg of pertuzumab and 600 mg of trastuzumab.
Each mL of solution contains 60 mg of pertuzumab and 60 mg of trastuzumab.
Phesgo 1200 mg/600 mg solution for injection: One vial of 15 mL solution contains 1200 mg of pertuzumab and 600 mg of trastuzumab.
Each mL of solution contains 80 mg of pertuzumab and 40 mg of trastuzumab.
Pertuzumab and trastuzumab are humanised immunoglobulin (Ig)G1 monoclonal antibodies produced in mammalian (Chinese hamster ovary) cells by recombinant deoxyribonucleic acid (DNA) technology.
Excipients/Inactive Ingredients: Vorhyaluronidase alfa; L-histidine; L-histidine hydrochloride monohydrate; α,α-trehalose dihydrate; Sucrose; L-methionine; Polysorbate 20 (E432); Water for injections.
